1557249-79-2

Upstream product

• 1557247-72-9 6,6-dimethyl-1-((2-(trimethylsilyl)ethoxy)methyl)-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid 
• 1557249-78-1 methyl-(4-amino-1H-pyrazol-1-yl)-2-phenylacetate 

Downstream Products

• 1557234-97-5 N-(1-((1R)-2-hydroxy-1-phenylethyl)-1H-pyrazol-4-yl)-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide 
• 1557235-01-4 N-(1-((1S)-2-hydroxy-1-phenylethyl)-1H-pyrazol-4-yl)-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide 
• 1557249-82-7 N-[1-(2-hydroxy-1-phenyl-ethyl)pyrazol-4-yl]-6,6-dimethyl-1-(2-trimethylsilylethoxymethyl)-5,7-dihydro-4H-indazole-3-carboxamide 
• 1557234-95-3 N-(1-(2-hydroxy-1-phenylethyl)-1H-pyrazol-4-yl)-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide 

Relevant academic research and scientific papers

PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Provided herein are compounds of formula (AA): N N H HN O N N R R 6 A (R a ) p, (AA) stereoisomers or a pharmaceutically acceptable salt thereof, wherein A, R a, p, R and R 6 are defined herein, compositions including the compounds and methods of manufacturing and using the compounds for the treatment of diseases.